Wolverine Trading
ALT icon

Wolverine Trading’s Altimmune ALT Stock Holding History

Wolverine Trading’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$164K Sell
43,200
-58,100
-57% -$224K ﹤0.01% 5024
2025
Q2 		$355K Buy
101,300
+55,600
+122% +$301K ﹤0.01% 3291
2025
Q1 		$243K Sell
45,700
-10,500
-19% -$66.5K ﹤0.01% 3750
2024
Q4 		$411K Buy
56,200
+16,900
+43% +$129K ﹤0.01% 3624
2024
Q3 		$254K Sell
39,300
-10,500
-21% -$71.1K ﹤0.01% 3805
2024
Q2 		$331K Buy
49,800
+3,300
+7% +$24.4K ﹤0.01% 3280
2024
Q1 		$473K Sell
46,500
-73,500
-61% -$748K ﹤0.01% 2897
2023
Q4 		$1.35M Buy
120,000
+105,400
+722% +$440K ﹤0.01% 2009
2023
Q3 		$38K Buy
14,600
+1,600
+12% +$4.59K ﹤0.01% 4231
2023
Q2 		$45.5K Sell
13,000
-21,300
-62% -$95.6K ﹤0.01% 3971
2023
Q1 		$145K Buy
34,300
+21,600
+170% +$257K ﹤0.01% 3549
2022
Q4 		$209K Sell
12,700
-4,400
-26% -$49.4K ﹤0.01% 3096
2022
Q3 		$216K Buy
+17,100
New +$252K ﹤0.01% 3525
2022
Q1 		– Sell
-41,600
Closed -$371K – 5336
2021
Q4 		$371K Buy
41,600
+1,100
+3% +$11.7K ﹤0.01% 3848
2021
Q3 		$517K Buy
40,500
+14,400
+55% +$175K ﹤0.01% 3888
2021
Q2 		$415K Hold
26,100
– – ﹤0.01% 3962
2021
Q1 		$354K Sell
26,100
-15,500
-37% -$251K ﹤0.01% 4232
2020
Q4 		$470K Buy
41,600
+21,400
+106% +$252K ﹤0.01% 3244
2020
Q3 		$263K Buy
20,200
+4,400
+28% +$88K ﹤0.01% 3546
2020
Q2 		$165K Buy
+15,800
New +$86.8K ﹤0.01% 3933
2017
Q3 		– Sell
-343
Closed -$31K – 4363
2017
Q2 		$31K Buy
343
+248
+261% +$41.2K ﹤0.01% 4119
2017
Q1 		$23K Buy
+95
New +$50.8K ﹤0.01% 4088
2016
Q4 		– Sell
-122
Closed -$103K – 4385
2016
Q3 		$103K Buy
+122
New +$95.7K ﹤0.01% 4174

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's ALT Position: Q3 2025 in Review

Wolverine Trading reduced its Altimmune (ALT) stake by 52% in Q3 2025, selling an estimated $91.5K and leaving 21,820 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5264.

Wolverine Trading first reported a position in ALT in Q4 2020 and has held it in 15 quarters since. The position peaked at $713K in Q4 2023. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Wolverine Trading held 21,820 shares of Altimmune worth $82.7K as of Q3 2025.
  • Wolverine Trading sold 23,708 Altimmune shares in Q3 2025, an estimated $91.5K.
  • Altimmune made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5264 holding.
  • Wolverine Trading first reported a position in Altimmune in Q4 2020 and has held it in 15 quarters since.
  • Wolverine Trading's Altimmune position peaked at $713K in Q4 2023.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.